Universitätsklinikum Frankfurt am Main (KGU)

The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML (2025) Stasik S, Eckardt JN, Röllig C, Baldus CD, Platzbecker U, Serve H, Müller-Tidow C, et al. Journal article A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research (2025) Metwaly A, Kriaa A, Hassani Z, Carraturo F, Druart C, Pinto F, Asnicar F, et al. Journal article Prevalence and prognostic role of thoracic lymphadenopathy in Covid-19. (2025) Sähn MJ, Wienke A, Meyer HJ, Dietz J, Vogl TJ, Borggrefe J, Gussew A, et al. Journal article The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (2025) Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, Augustin M, et al. Journal article Trio Exome Sequencing in VACTERL Association (2025) Ćomić J, Tilch E, Riedhammer KM, Brugger M, Brunet T, Eyring K, Vill K, et al. Journal article The prognostic relevance of pleural effusion in patients with COVID-19 - A German multicenter study (2025) Bucher AM, Dietz J, Ehrengut C, Müller L, Schramm D, Akinina A, Drechsel M, et al. Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland (2025) Denk A, Fante MA, Heidenreich S, Greinix HT, Drouet EMW, Egger-Heidrich K, Marx J, et al. Journal article Prognostic value of CT-defined coronary sclerosis in COVID-19: Results of a multicenter study based on the Weston score (2025) Bucher AM, Frodl E, Ehrengut C, Müller L, Emrich T, Kloeckner R, Sieren M, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum